GlassScriptPhysician profile
John D Carey
NPI 1346235561
$6,176.11
in general payments reported to CMS, 2019-2025
35 companies · $1,878 in 2025
The $1,878 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $926 · 2022: $949 · 2023: $1,261 · 2024: $1,162 · 2025: $1,878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,244 · Education: $57.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,243.53 |
| Education | $57.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $941.89 | 2021-2025 | Tezspire, Fasenra, Andexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $897.17 | 2021-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $642.98 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Grifols USA, LLC | $422.06 | 2021-2025 | Prolastin-C Liquid, Xembify |
| Mylan Specialty L.P. | $371.53 | 2021-2024 | Yupelri |
| Genzyme Corporation | $309.52 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $308.15 | 2024-2025 | Dupixent |
| Insmed, INC. | $295.13 | 2021-2025 | Arikayce, Brinsupri |
| Glaxosmithkline, LLC. | $221.60 | 2021-2025 | Nucala, Trelegy Ellipta |
| Mallinckrodt Hospital Products INC. | $196.72 | 2021-2024 | Acthar |
| Merck Sharp & Dohme LLC | $193.31 | 2023-2025 | Winrevair |
| Takeda Pharmaceuticals U.S.A., INC. | $177.06 | 2022-2025 | Glassia |
| United Therapeutics Corporation | $166.34 | 2021-2025 | Tyvaso, Tyvaso |
| Harmony Biosciences LLC | $135.75 | 2021-2025 | Wakix |
| Intuitive Surgical, INC. | $120.00 | 2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $111.33 | 2021-2024 | |
| Abbvie INC. | $91.13 | 2023-2025 | |
| Verona Pharma, INC. | $72.18 | 2025 | Ohtuvayre |
| Janssen Pharmaceuticals, INC | $68.54 | 2021 | |
| Baxter Healthcare | $64.73 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Sanofi-Aventis U.S. LLC | $57.48 | 2024 | |
| Shionogi INC | $48.93 | 2023 | Fetroja |
| Viatris Specialty LLC | $47.97 | 2025 | Yupelri |
| Optinose US, INC. | $24.35 | 2021 | |
| Vifor Pharma, INC. | $24.04 | 2025 | Zemaira |
| Liquidia Technologies, INC. | $23.91 | 2025 | Yutrepia |
| Ani Pharmaceuticals, INC. | $19.82 | 2023 | Purified Cortrophin Gel |
| Lilly USA, LLC | $19.23 | 2025 | Zepbound |
| Novartis Pharmaceuticals Corporation | $18.48 | 2023 | |
| La Jolla Pharmaceutical Company | $18.30 | 2023 | Giapreza |
| Advanced Respiratory, INC | $18.29 | 2021 | |
| Amgen INC. | $15.67 | 2025 | Tezspire |
| Pfizer INC. | $15.29 | 2024 | |
| Electromed, INC. | $12.85 | 2023 | Smartvest |
| Inogen, INC. | $4.38 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Carey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.